Kieron Dunleavy, MD | Authors

OSCO

1266 GRUBSTAKE CIR

Articles

Management of Primary Mediastinal B-Cell Lymphoma and Gray Zone Lymphoma

June 15, 2017

Over recent years, there has been much progress in elucidating the biology of these lymphomas, and this has paved the way for novel therapies that are currently under investigation in clinical trials.

Chronic Lymphocytic Leukemia and Hairy-Cell Leukemia

June 01, 2015

Chronic lymphocytic leukemia (CLL) is a clonal malignancy that results from expansion of the mature lymphocyte compartment. This expansion is a consequence of prolonged cell survival, despite a varied cell.

Appropriate Management of Molecular Subtypes of Diffuse Large B-Cell Lymphoma

April 15, 2014

The classification of diffuse large B-cell lymphoma into three distinct molecular diseases--germinal center B-cell–like subtype, an activated B-cell–like subtype, and a primary mediastinal B-cell lymphoma subtype--has laid the foundation for the development of new agents and novel strategies that target individual subtypes.